TransMedics Group

$14.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (+1.30%) Today
$0.00 (0.00%) As of 1:07 PM EST after-hours

Why Robinhood?

You can buy or sell TMDX and other stocks, options, and ETFs commission-free!

About TMDX

TransMedics Group, Inc. Common Stock, also called TransMedics Group, is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA. The listed name for TMDX is TransMedics Group, Inc. Common Stock.

CEO
Waleed H. Hassanein
Employees
109
Headquarters
Andover, Massachusetts
Founded
1998
Market Cap
401.71M
Price-Earnings Ratio
Dividend Yield
Average Volume
73.30K
High Today
$15.08
Low Today
$14.47
Open Price
$14.47
Volume
30.17K
52 Week High
$20.99
52 Week Low
$10.10

Collections

TMDX Earnings

-$4.86
-$3.24
-$1.62
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 1, After Hours

You May Also Like